High Dose Vitamin D Supplementation in Children With Sickle Cell Disease

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

February 10, 2024

Conditions
Sickle Cell DiseaseVitamin D DeficiencyHealth Related Quality of LifeHand Grip StrengthBone Mineral Density
Interventions
DRUG

Vitamin D3

Subjects within SCD as well as healthy controls, received monthly oral vitamin D3 dose, for 6 months, according to the baseline status of vitamin D as follows: sufficient (\>30 ng/mL): 100,000 IU, insufficient (20-29.9 ng/mL): 150,000 IU, and deficient (\<20 ng/mL): 200,000 IU.

Trial Locations (1)

44519

Zagazig university, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT06274203 - High Dose Vitamin D Supplementation in Children With Sickle Cell Disease | Biotech Hunter | Biotech Hunter